SFXN1 and neoplasm: Our data revealed that high SFXN1 expression was strongly associated with larger tumor sizes (P = 0.0055), lymph node involvement (P = 0.0096), distant organ metastasis (P = 0.0322), and advanced TNM staging (P < 0.0001) among these patients (Fig. 2B-E).